@article{11376,
  keywords = {drug utilization study, liraglutide, obesity therapy, off‐label potential, real‐world use, Type 2 diabetes},
  author = {T. Murray-Thomas and J. Dcruz and N. Harder-Lauridsen and A. Olsen and R. Williams and A. Major-Pedersen},
  title = {Real-world use of liraglutide for weight management according to label in the United Kingdom: A cohort study using the Clinical Practice Research Datalink primary care databases},
  year = {2025},
  journal = {Diabetes Obes Metab},
  edition = {2025/04/28},
  isbn = {1462-8902},
  doi = {10.1111/dom.16393},
  note = {1463-1326
Murray-Thomas, Tarita
Dcruz, John M
Harder-Lauridsen, Nina M
Olsen, Anne H
Williams, Rachael
Major-Pedersen, Atheline
Orcid: 0000-0002-1755-630x
Novo Nordisk/
Journal Article
England
Diabetes Obes Metab. 2025 Apr 28. doi: 10.1111/dom.16393.},
  language = {eng},
}